IS FAVORABLE INTERMEDIATE RISK PROSTATE CANCER REALLY FAVORABLE? IMPLICATIONS FOR ACTIVE SURVEILLANCE STRATEGIES

Haywood, S; Nyame, Y; Liang, H; Klein, E; Stephenson, A

JOURNAL OF UROLOGY, 2017; 197 (4): E1055